News and Events Category
Medical device companies Impulse Dynamics NV and MetaCure Ltd. have announced today the signing of a strategic Asia-Pacific distribution agreement with newly formed Australian company Vitality Devices Pty. Ltd. Australia (PRWEB) February 21, 2012 Under this agreement Vitality will distribute Impulse Dynamics’ OPTIMIZER System for treating Chronic Heart Failure (CHF) and MetaCure’s DIAMOND System for [...]
Read More
The Asia Pacific Workshop on Metabolic surgery took place in Singapore on February 6, 2012 The Chairman of the MetaCure Scientific Advisory Board, Prof. Harold Lebovitz, presented the Diamond System at the workshop, during his talk entitled ”Bariatric intervention with pacing/GI electric stimulation”.
Read More
DIAMOND System featured in the japanese show “the world’s astonishing news” discussing treatments for diabetes and obesity.
Read More
The favorable Benefit-Risk profile of the DIAMOND (TANTALUS) System , a minimally invasive gastric stimulator for treatment of Type 2 Diabetes and its metabolic comorbidities, developed by MetaCure, was presented at the Annual Meeting of the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) in Hamburg at the beginning of September. Prof. [...]
Read More
Israeli firm touts internal device for diabetes treatment JERUSALEM, July 19 (Xinhua) — An Israeli medical equipment company has began marketing a new device they say can treat type 2 diabetes without any drugs. Officials with Kfar Saba-based Metacure said the electrical device is implanted in the stomach’s outer muscles and works by contracting the [...]
Read More
Morbid obesity is a chronic, lifelong, multifactorial, constitutional disease with negative medical, psychological, physical, social and economic side-effects. Obesity-related secondary diseases are Type 2 diabetes mellitus (T2DM), cardiovascular diseases such as hypertension or sleep apnoea. Report: Holger Zorn With more than 300 million cases estimated worldwide, the World Health Organisation regards obesity as an epidemic [...]
Read More
MetaCure Treats Diabetes without Meds By Abigail Klein Leichman July 17, 2011 Attached to the stomach in a minimally invasive procedure, the Israeli-innovated device frees diabetics from pills and injections. DIAMOND is attached via electrodes to the stomach muscles. As disturbing new figures emerge that show that 350 million people worldwide now suffer from Type [...]
Read More
MetaCure Limited, developer of the DIAMOND System for treating Type 2 Diabetes, announced that Dr. Michael Berelowitz has joined the MetaCure Scientific Advisory Board, chaired by Prof. Harold Lebovitz. Kfar Saba, Israel (PRWEB) July 07, 2011 MetaCure Limited, developer of the DIAMOND System for treating Type 2 Diabetes, announced that Dr. Michael Berelowitz has [...]
Read More
A Sweet Life blog article, May 31, 2011 With today’s growing type 2 diabetes epidemic, there’s a need for new ways to treat the disease. Not everyone achieves good glycemic control with oral medications and some medications, like insulin, lead to weight gain. For type 2 diabetics who also suffer from obesity, any treatment that [...]
Read More
The article, published on April 18th on “The Gray Sheet” reveals the Company’s plans to wrap up three overseas trials by the end of 2012 for its DIAMOND electrostimulator implant for type 2 diabetes in obese patients and begin a pivotal U.S. trial within the next couple of years to support a PMA submission for [...]
Read More
